06/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

06/2024

Jun 2, 2024, 12:08 | Blog
Don’t miss the Helen Gurley Brown Presidential Summit on Women and Science at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on their X: "Don’t miss the Helen Gurley Brown Presidential Summit…
Jun 2, 2024, 12:03 | Blog
Drew Moghanaki: A look back at arguably the most important phase III RCT ever completed in the history of oncology
Drew Moghanaki shared on X: "Here is a look back at arguably the most important…
Jun 2, 2024, 12:00 | Blog
Glenn J. Hanna explains why HPV vaccination = cancer prevention at ASCO
ASCO shared on X/Twitter: "ASCO24 study suggests the HPV vaccine is effective in preventing the development…
Jun 2, 2024, 11:56 | Blog
Margaret Shipp has been inducted into the Giants of Cancer Care Program - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "Congratulations to Dana-Farber Cancer Institute’s Margaret Shipp, MD, who…
Jun 2, 2024, 11:49 | Blog
Charu Aggarwal: I look forward to attending sessions in the Women's Networking Lounge
Charu Aggarwal shared a post by Katherine Van Loon, Professor at the UCSF Helen Diller…
Jun 2, 2024, 11:48 | Blog
Yan Leyfman: MedNews Week is excited to partner with OncLive
Yan Leyfman, Internal Medicine Physician and Clinical Researcher at Icahn School of Medicine at Mount Sinai,…
Jun 2, 2024, 11:37 | Blog
Tarah Ballinger: Excited to present results of this trial focused solely on Black people with breast cancer at ASCO24
Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a…
Jun 2, 2024, 11:32 | Blog
Bishal Gyawali: Please don’t fall into the trap of hype listening to 'celebrity' experts
John Mandrola, Cardiac electrophysiologist at Baptist Health in Louisville, writer at Medscape and host of…
Jun 2, 2024, 11:17 | Societies
Elisa Agostinetto: Do patients with ER-low (1-10%) tumors benefit from adjuvant ET?
Hope Rugo, Professor of Medicine and Director of Breast Oncology and Clinical Trials Education at…
Jun 2, 2024, 11:16 | Insight
Giannis Mountzios: Lorlatinib in ALK positive NSCLC sets a new benchmark in Precision Oncology
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
All: 2740 Posts: 2601 - 2610
Special Coverage